Here are six takeaways:
1. By 2020, the market is expected to hit $818 million, increasing at a compound annual growing rate of 8.9 percent.
2. The market was valued at $447 million last year.
3. Factors spurring market growth include an increasing aging population, higher adoption of minimally invasive surgeries, more research and development activity in life sciences and an overall growth in healthcare infrastructure.
4. The escalated cost of equipment in developing regions may hinder market growth.
5. Asia-Pacific is expected to have the fastest growth through 2022 due to a growing population, more healthcare infrastructure initiatives and favorable reimbursement.
6. Key players include ACCU-SCOPE, Alltion, Haag-Streit U.S., Alcon Laboratories, Olympus, Leica Microsystem, ARRI , Carl Zeiss, Global Surgical, Topcon Medical Systems and TAKAGI SEIKO.
More device news:
FDA’s Center for Devices and Radiological Health zones in on health IT in 2017 — 5 insights
Global orthopedic devices market to hit $41.2B by 2019: 8 highlights
Nasseo awarded NSF grant for spinal implant research: 4 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
